drugset / Trial / NCT06053021
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NaSingle-groupOpen-labelPrevention
Summary
The goal of this clinical trial is to test the safety and effectiveness of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Participants will be prescribed antiplatelet agents and followed up for 3 months.
Timeline
- Start
- 2023-09-15
- Primary completion
- 2025-10-01
- Completion
- 2026-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | — |
| Subject | Cilostazol | Small molecule | — | — |
| Subject | Clopidogrel | Small molecule | — | — |
| Subject | Dipyridamole | Other / unclassified | — | — |